Literature DB >> 27160425

The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.

Li-Li Zhang1, Hong-Qi Liu1, Xu-Hong Yu1, Ying Zhang1, Jia-Sheng Tian1, Xu-Rui Song1, Bing Han2, Ai-Jun Liu1.   

Abstract

BACKGROUND AND AIMS: Severe motion sickness is a huge obstacle for people conducting precise aviation, marine or emergency service tasks. The combination of scopolamine and d-amphetamine is most effective in preventing severe motion sickness. However, this combination is not included in any present pharmacopoeia due to the abuse liability of d-amphetamine. We wanted to find a combination to replace it for the treatment of severe motion sickness. METHODS AND
RESULTS: We compared the efficacy of scopolamine, diphenhydramine, and granisetron (representing three classes of drugs) with different doses, and found that scopolamine was the most effective one. We also found scopolamine inhibited central nervous system at therapeutic doses and caused anxiety. Then, we combined it with different doses of psychostimulants (d-amphetamine, modafinil, caffeine) to find the best combination for motion sickness. The efficacy of scopolamine with modafinil (1 + 10 mg/kg) was equivalent to that of scopolamine with d-amphetamine (1 + 1 mg/kg); This combination also excited central nervous system and abolished the anxiety caused by scopolamine.
CONCLUSIONS: The optimal dose ratio of scopolamine and modafinil is 1:10. This combination is beneficial for motion sickness and can abolish the side effects of scopolamine. So, it might be a good replacement of scopolamine and d-amphetamine for severe motion sickness.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Locomotor Activity; Modafinil; Motion sickness; Scopolamine

Mesh:

Substances:

Year:  2016        PMID: 27160425      PMCID: PMC6492890          DOI: 10.1111/cns.12566

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  4 in total

Review 1.  Antihistamines for motion sickness.

Authors:  Nadine Karrim; Ryan Byrne; Nombulelo Magula; Yougan Saman
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

2.  Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness.

Authors:  Pingxiang Xu; Ying Liu; Liyun Wang; Yi Wu; Xuelin Zhou; Junhai Xiao; Jianquan Zheng; Ming Xue
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

3.  The mammalian efferent vestibular system utilizes cholinergic mechanisms to excite primary vestibular afferents.

Authors:  Glenn T Schneider; Choongheon Lee; Anjali K Sinha; Paivi M Jordan; Joseph C Holt
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 4.  Motion sickness: an overview.

Authors:  Alexander Kc Leung; Kam Lun Hon
Journal:  Drugs Context       Date:  2019-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.